About
IMAT is a potent and selective tyrosine kinase inhibitor that targets several key enzymes involved in the pathogenesis of various cancers. Its primary mechanism of action involves inhibiting the Bcr-Abl tyrosine kinase, which is characteristic of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). By binding to the ATP-binding site of Bcr-Abl, IMAT prevents the phosphorylation of downstream proteins, thereby blocking the signaling pathways that drive uncontrolled cell proliferation and survival in these leukemias. It also inhibits other receptor tyrosine kinases, including KIT and PDGF-R, making it effective in gastrointestinal stromal tumors (GIST) and certain myelodysplastic/myeloproliferative diseases.
This targeted therapy has revolutionized the treatment of CML, transforming a previously fatal disease into a manageable chronic condition for many patients. IMAT works by specifically interfering with the molecular abnormalities that cause these cancers, while largely sparing healthy cells. Its oral administration and high efficacy have made it a cornerstone of treatment for these specific malignancies, significantly improving patient outcomes and quality of life. Regular monitoring is essential to manage potential side effects and ensure optimal therapeutic response.
Uses
- Treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML).
- Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
- Treatment of unresectable and/or metastatic gastrointestinal stromal tumors (GIST).
- Treatment of myelodysplastic/myeloproliferative diseases associated with PDGF-R gene rearrangements.
Directions For Use
Take orally with a meal and a large glass of water to minimize gastrointestinal irritation. Do not crush or cut tablets.
Benefits
- Highly effective in CML and GIST.
- Targets specific cancer-driving enzymes.
- Oral administration for patient convenience.
- Significantly improves survival rates in CML.
- Reduces tumor burden and symptoms.
- Well-established safety and efficacy profile.
Side Effects
- Fluid retention (edema, especially periorbital)
- Nausea and vomiting
- Muscle cramps
- Diarrhea
- Fatigue
- Rash
- Abdominal pain
- Myelosuppression (neutropenia, thrombocytopenia, anemia)
- Hepatotoxicity
- Headache
- Skin discoloration
- Cardiac dysfunction (rare)
Safety Measures
- Alcohol - Avoid alcohol as it may increase the risk of liver toxicity or exacerbate gastrointestinal side effects.
- Pregnancy - Contraindicated in pregnancy due to potential for fetal harm. Effective contraception is required for both male and female patients.
- Breastfeeding - Breastfeeding is not recommended during treatment and for a period after the last dose due to potential harm to the infant.
- Liver - Use with caution in patients with hepatic impairment; dose adjustments are necessary. Monitor liver function closely.
- Kidney - Use with caution in patients with renal impairment; dose adjustments may be necessary. Monitor kidney function.
- Lung - Monitor for signs of interstitial lung disease or pneumonitis, especially in patients with pre-existing lung conditions.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!